Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$647,150
-$74,140 QoQ
Shares Held
26,875
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,585
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CALTON & ASSOCIATES, INC. holds $9,328,876 across 9 Drug Manufacturers - General names. PFE ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,827 | $3,390,788 | |
| 2 | JNJ |
Johnson & Johnson
|
6,320 | $1,605,090 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,693 | $1,245,550 | |
| 4 | ABBV |
AbbVie Inc.
|
4,822 | $1,213,408 | |
| 5 | PFE |
Pfizer Inc
This page
|
26,875 | $647,150 | |
| 6 | AMGN |
Amgen Inc
|
1,111 | $402,315 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,244 | $302,159 | |
| 8 | GSK |
GSK plc
|
5,418 | $284,011 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $647,150 | 26,875 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $721,290 | 25,687 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $785,097 | 31,530 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $628,591 | 24,670 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $428,029 | 17,658 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $466,053 | 18,392 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $331,173 | 12,483 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $505,437 | 17,465 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $704,452 | 25,177 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $261,793 | 9,434 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $334,165 | 11,607 | Shares | Sole | 2024-02-07 | |
| 2023-06-30 | $516,197 | 14,073 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $396,453 | 9,717 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $601,198 | 11,733 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $400,053 | 9,142 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $646,724 | 12,335 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $835,671 | 16,142 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,004,853 | 17,017 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $893,618 | 20,777 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,042,869 | 26,631 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,059,618 | 29,247 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,148,656 | 31,205 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,079,749 | 29,421 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $709,132 | 21,686 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $774,089 | 23,716 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||